发明名称 Diketopiperazine salts for drug delivery and related methods
摘要 Drug delivery systems have been developed based on the formation of diketopiperazine carboxylate salts and microparticles containing the same. The systems may further comprise a bioactive agent. Related methods for making and using the biologically active agent delivery compositions are also provided. In certain embodiments, the pharmaceutically acceptable salts described can be formed by removal of solvent by methods including distillation, evaporation, spray drying or lyophilization.
申请公布号 US9259471(B2) 申请公布日期 2016.02.16
申请号 US201414150474 申请日期 2014.01.08
申请人 MannKind Corporation 发明人 Leone-Bay Andrea;Moye-Sherman Destardi;Wilson Bryan R.
分类号 A61K31/4965;C07D241/02;A61K47/22;A61K31/357;A61K31/535;C07D241/08;A61K38/28 主分类号 A61K31/4965
代理机构 K&L Gates LLP 代理人 K&L Gates LLP ;Cullman Louis C.;Winn Robert W.
主权项 1. A microparticulate system for drug delivery comprising a composition comprising: microparticles of a pharmaceutically acceptable anion of a diketopiperazine compound comprising a carboxylate group, a divalent cation, and a biologically active agent, wherein the diketopiperazine compound is represented by the following general formula: wherein E1 and E2 are NH, and R1 and R2 are independently selected from succinate-4-aminobutyl, glutarate-4-aminobutyl, maleate-4-aminobutyl, citraconate-4-aminobutyl, malonate-4-aminobutyl, oxalate-4-aminobutyl, and fumarate-4-aminobutyl.
地址 Valencia CA US